Wyeth Kicks Off “Project Impact” As Protonix Generics Threaten Bottom Line
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug revenues jump 10 percent for the fourth quarter and full year, and dual-fronted patent fight goes on.